Selective adhesion-molecule therapy and inflammatory bowel disease.
Abhijit
A
Chaudhuri
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D015815:Cell Adhesion Molecules / Q000037:antagonists & inhibitors*; D003424:Crohn Disease / Q000150:complications / Q000188:drug therapy*; D003937:Diagnosis, Differential; D006801:Humans; D039001:Integrin alpha Chains / Q000037:antagonists & inhibitors; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced / Q000175:diagnosis*; D008279:Magnetic Resonance Imaging; D009103:Multiple Sclerosis / Q000175:diagnosis / Q000209:etiology; D000069442:Natalizumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D015815:Cell Adhesion Molecules; D039001:Integrin alpha Chains; D000069442:Natalizumab